XML 69 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Stock Option Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted Average Remaining Contractual Term, Begining 2 years 6 months  
2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Granted 65,508 44,113
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Granted 1,539 43,333
Non-Qualified Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Granted 26,230  
Non-Qualified Stock Options [Member] | 2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 95,007 67,567
Weighted Average Exercise Price, Outstanding Beginning $ 12.45 $ 14.40
Weighted Average Remaining Contractual Term, Begining 7 years 1 month 6 days 7 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding Beginning
Number of Options, Granted 65,508 44,113
Weighted Average Exercise Price, Granted $ 9.00 $ 10.50
Weighted Average Remaining Contractual Term, Granted 10 years 10 years
Number of Options, Exercised
Number of Options, Forfeited (2,341)
Number of Options, Forfeited/Cancelled (16,673)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price   $ 15.15
Weighted Average Remaining Contractual Term, Expired   4 years 3 months 18 days
Aggregate Intrinsic Value, Granted  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price $ 16.83  
Weighted Average Remaining Contractual Term, Forfeited 7 years  
Aggregate Intrinsic Value, Forfeited  
Number of Options, Outstanding Ending 158,174 95,007
Weighted Average Exercise Price, Outstanding Ending $ 10.99 $ 12.45
Weighted Average Remaining Contractual Term, Ending 7 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding Ending
Number of Options, Exercisable Ending 116,328  
Weighted Average Exercise Price, Exercisable Ending $ 12.12  
Weighted Average Remaining Contractual Term, Exercisable Ending 6 years 9 months 18 days  
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Forfeited/Cancelled 2,341
Number of Options, Expired 16,673
Aggregate Intrinsic Value, Outstanding Ending
Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 49,333 6,000
Weighted Average Exercise Price, Outstanding Beginning $ 10.05 $ 20.25
Weighted Average Remaining Contractual Term, Begining 4 years 6 months 7 years 7 months 6 days
Aggregate Intrinsic Value, Outstanding Beginning
Number of Options, Granted 1,539 43,333
Weighted Average Exercise Price, Granted $ 9.75 $ 8.55
Weighted Average Remaining Contractual Term, Granted 10 years 8 years 6 months
Number of Options, Exercised
Number of Options, Forfeited
Number of Options, Forfeited/Cancelled
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price  
Aggregate Intrinsic Value, Granted  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price  
Number of Options, Outstanding Ending 50,872 49,333
Weighted Average Exercise Price, Outstanding Ending $ 10.02 $ 10.05
Weighted Average Remaining Contractual Term, Ending 6 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding Ending
Number of Options, Exercisable Ending 50,872  
Weighted Average Exercise Price, Exercisable Ending $ 10.02  
Weighted Average Remaining Contractual Term, Exercisable Ending 6 years 7 months 6 days  
Aggregate Intrinsic Value, Exercisable Ending  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price  
Number of Options, Forfeited/Cancelled
Number of Options, Expired
Aggregate Intrinsic Value, Outstanding Ending